7IMF

Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) -- Crystal Structure of SARS-CoV-2 nucleocapsid protein (CTD) in complex with Z2697514548 (Nprot-x0390)

Summary for 7IMF

• Entry DOI: 10.2210/pdb7imf/pdb
• Group deposition: Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) (G_1002353)
• Descriptor: Nucleoprotein, 1-methylindazole-3-carboxamide, DI(HYDROXYETHYL)ETHER, ... (5 entities in total)
• Functional Keywords: diamond i04-1, pandda2, xchemexplorer, crystallographic fragment screening, sars-cov-2, nucleocapsid protein, n protein, viral protein
• Biological source: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2); More
• Total number of polymer chains: 1
• Total formula weight: 13695.43

Authors

Aschenbrenner, J.C.,Luptak, J.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F. (deposition date: 2025-08-11, release date: 2026-08-26)

• Primary citation: Luptak, J.,Aschenbrenner, J.C.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F.; Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD); To Be Published,

Experimental method

X-RAY DIFFRACTION (1.56 Å)